210 related articles for article (PubMed ID: 17951398)
1. Automated scanning electron microscopy and x-ray microanalysis for in situ quantification of gadolinium deposits in skin.
Thakral C; Abraham JL
J Electron Microsc (Tokyo); 2007 Oct; 56(5):181-7. PubMed ID: 17951398
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-induced nephrogenic systemic fibrosis is associated with insoluble Gd deposits in tissues: in vivo transmetallation confirmed by microanalysis.
Thakral C; Abraham JL
J Cutan Pathol; 2009 Dec; 36(12):1244-54. PubMed ID: 19602073
[TBL] [Abstract][Full Text] [Related]
3. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P
Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
High WA; Ayers RA; Chandler J; Zito G; Cowper SE
J Am Acad Dermatol; 2007 Jan; 56(1):21-6. PubMed ID: 17097388
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic systemic fibrosis: histology and gadolinium detection.
Thakral C; Abraham JL
Radiol Clin North Am; 2009 Sep; 47(5):841-53, vi-vii. PubMed ID: 19744599
[TBL] [Abstract][Full Text] [Related]
6. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
Sanyal S; Marckmann P; Scherer S; Abraham JL
Nephrol Dial Transplant; 2011 Nov; 26(11):3616-26. PubMed ID: 21441397
[TBL] [Abstract][Full Text] [Related]
7. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
Abraham JL; Thakral C
Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532
[TBL] [Abstract][Full Text] [Related]
8. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Broome DR
Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
Kalb RE; Helm TN; Sperry H; Thakral C; Abraham JL; Kanal E
Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis: more questions and some answers.
Morcos SK; Thomsen HS
Nephron Clin Pract; 2008; 110(1):c24-31; discussion c32. PubMed ID: 18688172
[TBL] [Abstract][Full Text] [Related]
11. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
[TBL] [Abstract][Full Text] [Related]
12. Long-term retention of gadolinium in tissues from nephrogenic systemic fibrosis patient after multiple gadolinium-enhanced MRI scans: case report and implications.
Thakral C; Alhariri J; Abraham JL
Contrast Media Mol Imaging; 2007 Jul; 2(4):199-205. PubMed ID: 17712863
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium deposition in nephrogenic fibrosing dermopathy.
Boyd AS; Zic JA; Abraham JL
J Am Acad Dermatol; 2007 Jan; 56(1):27-30. PubMed ID: 17109993
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray spectroscopy.
Xia D; Davis RL; Crawford JA; Abraham JL
Acta Radiol; 2010 Dec; 51(10):1126-36. PubMed ID: 20868305
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic system fibrosis: a radiologist's practical perspective.
Martin DR
Eur J Radiol; 2008 May; 66(2):220-4. PubMed ID: 18321672
[TBL] [Abstract][Full Text] [Related]
16. Synchrotron X-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis.
George SJ; Webb SM; Abraham JL; Cramer SP
Br J Dermatol; 2010 Nov; 163(5):1077-81. PubMed ID: 20560953
[TBL] [Abstract][Full Text] [Related]
17. Nephrogenic systemic fibrosis--implications for nephrologists.
Saab G; Abu-Alfa A
Eur J Radiol; 2008 May; 66(2):208-12. PubMed ID: 18342470
[TBL] [Abstract][Full Text] [Related]
18. [Nephrogenic systemic fibrosis].
Breitschaft A; Stahlmann R
Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
[TBL] [Abstract][Full Text] [Related]
20. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
Grant D; Johnsen H; Juelsrud A; Løvhaug D
Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]